DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Cheever MA, Higano CS.
PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
Clin Cancer Res 2011;
17 (11) 3520-3526
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.